跳至主要内容
临床试验/NCT04114006
NCT04114006已完成不适用

Initial Analysis of Wide-area Transepithelial Sampling for the Detection of Gastric Neoplasia

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Diagnostic yield of the WATS approach versus standard gastric biopsy mapping

研究概览

简要总结

Potential patients will be recruited at participating sites based on routine care with clinical indications for upper endoscopy. Following informed consent, patients will undergo their scheduled endoscopy with standard forceps biopsies along with the transepithelial brush samples. All samples, biopsy and brush samples, will be sent for pathology analysis, per standard clinical practice.

详细描述

Potential patients will be recruited at participating sites based on routine care with clinical indications for upper endoscopy. Following informed consent, patients will undergo their scheduled endoscopy with standard forceps biopsies along with the transepithelial brush samples. All samples, biopsy and brush samples, will be sent for histologic analysis, with planned study of the diagnostic yields of each method.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is informed of the investigational nature of this study and given verbal and written informed consent in accordance with local, U.S., and international guidelines.
  • Both males and females at least 18 years.
  • Patients with clinical indications for upper endoscopy

排除标准

  • Patients should not have an advanced medical or psychiatric conditions which that may limit their ability to participate in the study, as judged by the physician.

结局指标

主要结局

Diagnostic yield of the WATS approach versus standard gastric biopsy mapping

时间窗: 1-3 Years

To compare the diagnostic yield of the WATS approach versus standard gastric biopsy mapping (per the updated Sydney system).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Douglas Morgan MD

Professor of Medicine, Director, Division of Gastroenterology/ Hepatology

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验

Novel Screening Modality for Early Gastric Cancer | 临床试验